Practice Guidelines

Lyme Disease: Updated Recommendations from the IDSA, AAN, and ACR

 

Am Fam Physician. 2021 Dec ;104(6):652-654.

Author disclosure: No relevant financial affiliations.

Key Points for Practice

• Prophylaxis for Lyme disease is most beneficial for high-risk bites, which include those from an Ixodes tick in an endemic area that was attached for at least 36 hours.

• Antibiotic treatment is recommended for classic erythema migrans or a possible Lyme presentation with positive serum antibody testing.

• Routine testing for Lyme disease is not beneficial in psychiatric disorders, behavior disorders, or chronic cardiomyopathy.

From the AFP Editors

Lyme disease, a tick-borne spirochete infection caused by Borrelia burgdorferi, is most common in three regions in the United States—the northeastern states from Virginia to Maine; the upper Midwest, especially Wisconsin and Minnesota; and northern California. A multidisciplinary panel representing the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR) has published recommendations on the prevention, diagnosis, and treatment of Lyme disease.

Prevention of Lyme Disease

The key to preventing Lyme disease is to avoid tick bites and prolonged tick attachment. Basic protection measures include avoiding risky areas, wearing long sleeves and pants, tucking pants into socks, and using clothing treated with permethrin. Unlike permethrin, many effective repellants are safe to apply to skin including N,N-diethyl- m-toluamide (DEET), picaridin, ethyl-3-(N-n-butyl-N-acetal) aminopropionate (IR3535), oil of lemon eucalyptus, p-methane-3,8-diol (PMD), and 2-undecanone.

Because spirochete transmission occurs after at least 36 hours of attachment, ticks should be removed promptly after discovery. After exposure to a tick habitat, thorough tick checks of exposed and intertriginous skin, bathing within two hours, and drying clothes for at least one hour on high heat can prevent disease. Ticks can be removed with tweezers and placed in a bag for later identification. To remove ticks, fine-tipped tweezers should be used to grasp the mouth parts as close to the skin as possible and steady traction applied directly away from the skin. Because B. burgdorferi in ticks does not predict infection in humans, testing ticks is not recommended.

High-risk tick bites include those from an Ixodes tick in an endemic area that was attached for 36 hours or more. When all high-risk criteria are met, prophylactic treatment in adults and children with a single dose of doxycycline within 72 hours of tick removal (Table 1) is recommended. Without all high-risk features, monitoring for symptoms is as effective as treatment. Serologic testing following tick exposure in a patient with no symptoms is not helpful.

 Enlarge     Print

TABLE 1.

Antibiotic Recommendations for Common Lyme Presentations

PresentationTreatmentNotes

Lyme disease prophylaxis

Doxycycline, 200 mg as a single dose

High-risk bite: tick is Ixodes species, Lyme endemic area, tick attached for at least 36 hours Treatment recommended within 72 hours of tick removal For children, doxycycline, 4.4 mg per kg up to 200 mg

Erythema migrans

Doxycycline, 100 mg twice daily for 10 days or Amoxicillin, 500 mg three times daily for 14 days or Cefuroxime axetil (Ceftin), 500 mg twice daily for 14 days or Azithromycin (Zithromax), 500 mg daily for 7 days

Azithromycin only recommended for patients unable to take doxycycline and beta-lactam antibiotics

TABLE 1.

Antibiotic Recommendations for Common Lyme Presentations

PresentationTreatmentNotes

Lyme disease prophylaxis

Doxycycline, 200 mg as a single dose

High-risk bite: tick is Ixodes species, Lyme endemic area, tick attached for at least 36 hours Treatment recommended within 72 hours of tick removal For children, doxycycline, 4.4 mg per kg up to 200 mg

Erythema migrans

Doxycycline, 100 mg twice daily for 10 days or Amoxicillin, 500 mg three times daily for 14 days or Cefuroxime axetil (Ceftin), 500 mg twice daily for 14 days or Azithromycin (Zithromax), 500 mg daily for 7 days

Azithromycin only recommended for patients unable to take doxycycline and beta-lactam antibiotics

Erythema Migrans

For skin lesions that are typical for erythema migrans, empiric treatment for Lyme disease is recommended. The primary treatment is doxycycline, 100 mg twice daily for 10 days in adults, or one of several alternate regimens (Table 1). Testing is not helpful with typical erythema migrans.

For skin lesions that are atypical for erythema migrans, serum antibody testing is recommended with follow-up convalescent phase testing for negative results. Serology is the most accurate testing method for Lyme disease, despite false negatives that can occur with acute illness. Antibody testing is universally recommended over polymerase chain reaction testing or culture. Antibodies remain elevated after infection, making diagnosis of repeat infections challenging.

If a patient has a high-grade fever for more than one day while receiving

Coverage of guidelines from other organizations does not imply endorsement by AFP or the AAFP.

This series is coordinated by Michael J. Arnold, MD, contributing editor.

A collection of Practice Guidelines published in AFP is available at https://www.aafp.org/afp/practguide.

 

 

Copyright © 2021 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions

CME Quiz

More in AFP

MOST RECENT ISSUE


May 2022

Access the latest issue of American Family Physician

Read the Issue


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article